Health-Related Quality of Life in a Real-World Cohort of Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors [0.03%]
免疫检查点抑制剂治疗晚期尿路上皮癌患者的真实世界队列的健康相关生活质量研究
Hiroki Kobayashi,Nobuki Furubayashi,Kaede Morihara et al.
Hiroki Kobayashi et al.
Introduction: Health-related quality of life (HRQOL) has been reported in clinical trials of pembrolizumab and avelumab treatment of locally advanced or metastatic urothelial carcinoma. However, few studies have investiga...
Non-small cell lung cancer treated with epidermal growth factor receptor inhibitors: the effect of concurrent medications on patient outcomes [0.03%]
表皮生长因子受体抑制剂治疗的非小细胞肺癌：合并用药对患者预后的影响
Otto Manninen,Sanna Iivanainen,Martti Arffman et al.
Otto Manninen et al.
Introduction: EGFR tyrosine kinase inhibitor (TKI)-induced rash can be alleviated with tetracyclines (TCN) and topical corticosteroids (TCS), whereas drugs for acid-related disorders (DARD) can affect EGFR TKI absorption....
Analysis of Pleiotropic Effects of Nivolumab in Patients with relapsed Pleural Mesothelioma: A Single center retrospective study [0.03%]
尼伏单抗治疗复发性恶性胸膜间皮瘤的多效性分析：一项单中心回顾性研究
Tomoki Higashiyama,Kozo Kuribayashi,Hiroshi Doi et al.
Tomoki Higashiyama et al.
Introduction: In August 2018, the Japanese PMDA approved nivolumab, an immune checkpoint inhibitor (ICI), for previously treated, unresectable, advanced, or recurrent pleural mesothelioma (PM) based on the MERIT trial, a ...
A Comparative Study On The Progression Of Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms [0.03%]
神经内分泌癌和混合型神经内分泌-非神经内分泌肿瘤的进展比较研究
Xiaoling Duan,Man Zhao,Xiaolei Yin et al.
Xiaoling Duan et al.
Introduction: The prognostic differences between neuroendocrine carcinoma (NEC) and mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) remain unclear. ...
Predictive Value of Preoperative Peak Oxygen Uptake for Postoperative Pulmonary Complications in Lung Cancer Patients with Chronic Obstructive Pulmonary Disease: A Single-center Retrospective Cohort Study [0.03%]
术前峰值摄氧量对慢性阻塞性肺疾病伴发肺癌患者术后肺部并发症预测价值的单中心回顾性队列研究
Masaya Noguchi,Toshiki Takemoto,Masashi Shiraishi et al.
Masaya Noguchi et al.
Introduction: The relationship between preoperative peak oxygen uptake/weight (VO2/W) and postoperative pulmonary complications (PPC) in lobectomies, including video-assisted thoracoscopic surgery, remains unclear. Tradit...
Development and Validation of a Model Predicting Malignant Potential of Adnexal Masses in Areas with Scarcity of Ultrasound Resources [0.03%]
资源匮乏地区卵巢肿瘤恶性潜能预测模型的开发和验证
Guangxia Cui,Yu Guo,Wenpei Bai
Guangxia Cui
Introduction: Appropriately stratifying the risk of adnexal masses is of great importance. Many diagnostic algorithms have been devised, most of which rely on ultrasound features. However, some remote areas lack trained s...
Adjuvant sequential chemotherapy for salivary duct carcinomas: a retrospective comparative analysis [0.03%]
腮腺导管癌序贯辅助化疗的回顾性分析研究
Younghac Kim,Nayeon Choi,Eun-Hye Kim et al.
Younghac Kim et al.
Introduction: This study aimed to report the efficacy and safety of adjuvant sequential chemotherapy after definitive treatment of salivary duct carcinoma (SDC) compared with the standard treatment alone (surgery with pos...
Comparison of the efficacy of nal-IRI+5FU/LV and S-1 in patients with advanced pancreatic cancer refractory to gemcitabine and nab-paclitaxel [0.03%]
纳米脂质体伊立替康联合氟尿嘧啶/亚叶酸钙对比苏尼替尼治疗吉西他滨和白蛋白结合型紫杉醇耐药的晚期胰腺癌患者的疗效比较
Kazuhisa Yamaguchi,Yoshinori Kikuchi,Yusuke Kimura et al.
Kazuhisa Yamaguchi et al.
Introduction: Nanoliposomal irinotecan (nal-IRI) + 5- fluorouracil (FU)/leucovorin (LV) is the new standard second-line therapy for advanced pancreatic cancer (PC). Tegafur, gimeracil, and oteracil potassium (S-1) have be...
Investigating the Mechanism of Hedysarum Multijugum Maxim in the Treatment of Liver Cancer through Network Pharmacology and Molecular Docking Validation [0.03%]
基于网络药理学和分子对接验证探究 Hedysarum multijugum Maxim 治疗肝癌的作用机制
Nan Wang,Liwen Tang,Ronghui Duan et al.
Nan Wang et al.
Introduction: Hedysarum Multijugum Maxim (HMM), a Chinese traditional medicine , exerts anti-tumor effects and has been extensively studied for its potential to treat cancer in recent years. Clinical research has shown th...
Predicting High-Risk Patients with Lung Adenocarcinoma: The Power of Plasma Cell-Related Genes [0.03%]
预测肺癌高风险患者：基于血浆细胞相关基因的力量
Jiameng Gao,Xianqiang Zhou,Weibin Tian et al.
Jiameng Gao et al.
Background：The incidence of lung cancer remains high worldwide and is still the leading cause of cancer-related deaths globally.The primary reason for this is that the vast majority of patients are diagnosed only when the disease has progres...